相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pertussis re-emergence in the post-vaccination era
Elena Chiappini et al.
BMC INFECTIOUS DISEASES (2013)
Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort
Maxwell A. Witt et al.
CLINICAL INFECTIOUS DISEASES (2013)
Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates
J. M. Warfel et al.
MUCOSAL IMMUNOLOGY (2013)
Sevenfold rise in likelihood of pertussis test requests in a stable set of Australian general practice encounters, 2000-2011
Marlena C. Kaczmarek et al.
MEDICAL JOURNAL OF AUSTRALIA (2013)
Priming with Whole-Cell versus Acellular Pertussis Vaccine
Juventila Liko et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
THE PROTECTIVE ROLE OF MATERNALLY DERIVED ANTIBODIES AGAINST BORDETELLA PERTUSSIS IN YOUNG INFANTS
Ulrich Heininger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains
Audrey J. King et al.
PLOS ONE (2013)
Pregnancy Dose Tdap and Postpartum Cocooning to Prevent Infant Pertussis: A Decision Analysis
Andrew Terranella et al.
PEDIATRICS (2013)
Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers
Nicola P. Klein et al.
PEDIATRICS (2013)
Nonmedical Vaccine Exemptions and Pertussis in California, 2010
Jessica E. Atwell et al.
PEDIATRICS (2013)
Waning Immunity to Pertussis Following 5 Doses of DTaP
Sara Y. Tartof et al.
PEDIATRICS (2013)
Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies
Monika Polewicz et al.
VACCINE (2013)
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults-A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience
Birgit Thierry-Carstensen et al.
VACCINE (2013)
Bordetella pertussis iron regulated proteins as potential vaccine components
Jimena Alvarez Hayes et al.
VACCINE (2013)
Effectiveness of pertussis vaccines for adolescents and adults: case-control study
Roger Baxter et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
Padraig J. Ross et al.
PLOS PATHOGENS (2013)
Association Between Undervaccination With Diphtheria, Tetanus Toxoids, and Acellular Pertussis (DTaP) Vaccine and Risk of Pertussis Infection in Children 3 to 36 Months of Age
Jason M. Glanz et al.
JAMA PEDIATRICS (2013)
Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
Wasin Buasri et al.
BMC MICROBIOLOGY (2012)
Nonhuman Primate Model of Pertussis
Jason M. Warfel et al.
INFECTION AND IMMUNITY (2012)
Incomplete Financial Disclosure in a Viewpoint on Complementary and Alternative Therapies
Paul A. Offit
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010
Lara K. Misegades et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Immunity to the respiratory pathogen Bordetella pertussis
R. Higgs et al.
MUCOSAL IMMUNOLOGY (2012)
Accord could make Canadian generics industry a 'rust bucket'
Hannah Hoag
NATURE MEDICINE (2012)
Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
Nicola P. Klein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan
Nao Otsuka et al.
PLOS ONE (2012)
Pertussis control: time for something new?
Thomas A. Clark et al.
TRENDS IN MICROBIOLOGY (2012)
Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine
Joanna Kubler-Kielb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis
Srinivas Garlapati et al.
VACCINE (2011)
Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate
Cristian J. A. Asensio et al.
VACCINE (2011)
Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations
Aleksandra Gracia et al.
VACCINE (2011)
Development of improved vaccines against whooping cough Current status
Ibrahim Marzouqi et al.
HUMAN VACCINES (2010)
Inflammasome Activation by Adenylate Cyclase Toxin Directs Th17 Responses and Protection against Bordetella pertussis
Aisling Dunne et al.
JOURNAL OF IMMUNOLOGY (2010)
Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
Sabine C. de Greeff et al.
PLOS ONE (2010)
First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin
V. Bouchez et al.
VACCINE (2009)
Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
Frits R. Mooi et al.
EMERGING INFECTIOUS DISEASES (2009)
Modulation of the infant immune responses by the first pertussis vaccine administrations
F. Mascart et al.
VACCINE (2007)
分享论文
